Filing Flows › Endovia Health Sciences (EDVA) › Q1 2025
Endovia Health Sciences (EDVA) Q1 2025 earnings results (first quarter 2025)
10-Q filed Jul 11, 2025
Endovia Health Sciences (EDVA) reported revenue of $438K for the first quarter 2025 (Q1 2025), -72% from a year earlier and -25% from the quarter before. Operating margin was -463.8%, net loss $3.7M (832.9% of revenue).
Endovia Health Sciences, Q1 2025: revenue $438K (-72% year over year), operating margin -463.8%, net loss $3.7M, operating cash flow −$724K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $438K | -25% | -72% |
| Operating profit | −$2.0M | — | — |
| Net earnings | −$3.7M | — | — |
| Operating cash flow | −$724K | — | — |
What changed
Revenue was $438K in Q1 2025, down 72% year over year and down 25% from the previous quarter.
Operating costs exceeded revenue by $2.0M, an operating margin of -463.8%. The quarter ended with a net loss of $3.7M, narrower than the previous quarter's $9.0M loss.
Operating cash flow was −$724K. Non-cash charges added back $37K of depreciation and $141K of share-based compensation. Working capital and other items added $2.7M.
Questions
What was Endovia Health Sciences' revenue in the first quarter 2025?
Endovia Health Sciences (EDVA) reported revenue of $438K for the first quarter 2025 (Q1 2025), -72% from a year earlier and -25% from the quarter before.
Was Endovia Health Sciences profitable in the first quarter 2025?
Operating loss was $2.0M (-463.8% of revenue) and net loss $3.7M.